These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34601599)

  • 21. Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
    Kazmi N; Robinson T; Zheng J; Kar S; Martin RM; Ridley AJ
    Sci Rep; 2022 Jan; 12(1):1463. PubMed ID: 35087170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of a Causal Effect of Estradiol on Fracture Risk in Men.
    Nethander M; Vandenput L; Eriksson AL; Windahl S; Funck-Brentano T; Ohlsson C
    J Clin Endocrinol Metab; 2019 Feb; 104(2):433-442. PubMed ID: 30215726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
    Lundin E; Wirgin I; Lukanova A; Afanasyeva Y; Krogh V; Axelsson T; Hemminki K; Clendenen TV; Arslan AA; Ohlson N; Sieri S; Roy N; Koenig KL; Idahl A; Berrino F; Toniolo P; Hallmans G; Försti A; Muti P; Lenner P; Shore RE; Zeleniuch-Jacquotte A
    Cancer Epidemiol; 2012 Oct; 36(5):445-52. PubMed ID: 22633539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study.
    Vithayathil M; Carter P; Kar S; Mason AM; Burgess S; Larsson SC
    PLoS Med; 2021 Jul; 18(7):e1003706. PubMed ID: 34324486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.
    Sasano H; Harada N
    Endocr Rev; 1998 Oct; 19(5):593-607. PubMed ID: 9793759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
    Brown SB; Hankinson SE
    Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
    Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
    BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between cholelithiasis, cholecystectomy, and risk of breast and gynecological cancers: Evidence from meta-analysis and Mendelian randomization study.
    Peng J; Li L; Ning H; Li X
    Ann Hum Genet; 2024 Nov; 88(6):423-435. PubMed ID: 38989824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.
    Low YL; Li Y; Humphreys K; Thalamuthu A; Li Y; Darabi H; Wedrén S; Bonnard C; Czene K; Iles MM; Heikkinen T; Aittomäki K; Blomqvist C; Nevanlinna H; Hall P; Liu ET; Liu J
    PLoS Genet; 2010 Jul; 6(7):e1001012. PubMed ID: 20617168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study.
    Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
    Front Endocrinol (Lausanne); 2021; 12():756137. PubMed ID: 34803918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
    Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-sex cord-stromal ovarian tumors frequently produce and secrete estrogen in postmenopausal women: impact on bone metabolism and abnormal endometrial histology.
    Matsumura S; Ohta T; Takahashi T; Yamazaki T; Takahashi K; Kurachi H
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2775-82. PubMed ID: 23780377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis.
    Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Martin RM; Lewis SJ; Kazmi N; Robinson TM; Albanes D; Aleksandrova K; Berndt SI; Timothy Bishop D; Brenner H; Buchanan DD; Bueno-de-Mesquita B; Campbell PT; Castellví-Bel S; Chan AT; Chang-Claude J; Ellingjord-Dale M; Figueiredo JC; Gallinger SJ; Giles GG; Giovannucci E; Gruber SB; Gsur A; Hampe J; Hampel H; Harlid S; Harrison TA; Hoffmeister M; Hopper JL; Hsu L; María Huerta J; Huyghe JR; Jenkins MA; Keku TO; Kühn T; La Vecchia C; Le Marchand L; Li CI; Li L; Lindblom A; Lindor NM; Lynch B; Markowitz SD; Masala G; May AM; Milne R; Monninkhof E; Moreno L; Moreno V; Newcomb PA; Offit K; Perduca V; Pharoah PDP; Platz EA; Potter JD; Rennert G; Riboli E; Sánchez MJ; Schmit SL; Schoen RE; Severi G; Sieri S; Slattery ML; Song M; Tangen CM; Thibodeau SN; Travis RC; Trichopoulou A; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Vodicka P; White E; Wolk A; Woods MO; Wu AH; Peters U; Gunter MJ; Murphy N
    Nat Commun; 2020 Jan; 11(1):597. PubMed ID: 32001714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
    Dunbier AK; Anderson H; Ghazoui Z; Folkerd EJ; A'hern R; Crowder RJ; Hoog J; Smith IE; Osin P; Nerurkar A; Parker JS; Perou CM; Ellis MJ; Dowsett M
    J Clin Oncol; 2010 Mar; 28(7):1161-7. PubMed ID: 20124184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.
    Napoli N; Rastelli A; Ma C; Yarramaneni J; Vattikutti S; Moskowitz G; Giri T; Mueller C; Kulkarny V; Qualls C; Ellis M; Armamento-Villareal R
    Bone; 2013 Aug; 55(2):309-14. PubMed ID: 23643682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP19 (aromatase) haplotypes and endometrial cancer risk.
    Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
    Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.